Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions express strong support and curiosity about the research, with examples like 'reverse remodeling' and mentions of 'favorable effects' indicating perceived clinical importance. The tone is positive and recalls specific results, such as the lack of RV dysfunction over two years, reflecting moderate engagement and high perceived impact of the findings.
Most discussions support the positive effects of the atrial shunt device, emphasizing findings such as 'reverse remodeling' and 'favorable effects' from recent studies.
The discussions demonstrate high interest, with repeated references to specific research outcomes, clinical implications, and ongoing questions about long-term effects.
Several posts delve into detailed analysis, such as the mention of 'no change in RV systolic function' and 'long-term effects,' showing moderate physical and technical engagement.
Participants seem to believe the research could influence future treatments for heart failure with preserved ejection fraction, indicated by phrases like 'favorable effects' and references to what the data mean for clinical practice.
Over 2 years of follow-up, atrial shunting in patients with HFpEF and HFmrEF led to reverse remodeling of left-sided chambers and increases in volume of right-sided chambers but no change in RV systolic function compared with sham. https://t.co/qtdBf3VumJ https://t.co/BLpkoc2bAE
Interview with Sanjiv J. Shah, MD, author of "Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial" hosted by James E. Udelson, MD. @HFpEF https://t.co/zKvgy0sfFd
Over 2 years of follow-up, atrial shunting in patients with HFpEF and HFmrEF led to reverse remodeling of left-sided chambers and increases in volume of right-sided chambers but no change in RV systolic function compared with sham. https://t.co/aEhCWnHlSi
Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction The REDUCE LAP-HF II Randomized Clinical Trial no evidence of RV dysfunction over the initial 2 years https://t.co/GGOpZ0RXIv
Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction The REDUCE LAP-HF II Randomized Clinical Trial no evidence of RV dysfunction over the initial 2 years https://t.co/GGOpZ0RXIv
What is the long-term effect of an #atrialshunt? Recently published data in @JAMACardio by @RBPatelMD shows favorable effects of the Corvia Atrial Shunt on cardiac structure & function in #heartfailure patients. #HFpEF #cardiotwitter https://t.co/wMGwBUNxtc
The REDUCE LAP-HF II trial evaluated the impact of the Corvia Medical Inc IASD System II atrial shunt on cardiac structure and function in heart failure patients, showing potential benefits such as reduced ventricular…
Congratulations to #TPCH's S. McKenzie for their contribution to the publication "Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial" https://t.co/6STdkJpzr5
Over 2 years of follow-up, atrial shunting in patients with HFpEF and HFmrEF led to reverse remodeling of left-sided chambers and increases in volume of right-sided chambers but no change in RV systolic function compared with sham. https://t.co/aEhCWnHlSi
Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction The REDUCE LAP-HF II Randomized Clinical Trial no evidence of RV dysfunction over the initial 2 years https://t.co/GGOpZ0RXIv
RT @corviamedical: What is the long-term effect of an #atrialshunt? Recently published data in @JAMACardio by @RBPatelMD shows favorable ef…
What is the long-term effect of an #atrialshunt? Recently published data in @JAMACardio by @RBPatelMD shows favorable effects of the Corvia Atrial Shunt on cardiac structure & function in #heartfailure patients. #HFpEF #cardiotwitter https://t.co/wMGwBUNxtc
Interview with Sanjiv J. Shah, MD, author of "Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial" hosted by James E. Udelson, MD. @HFpEF https://t.co/zKvgy0sfFd
Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction The REDUCE LAP-HF II Randomized Clinical Trial no evidence of RV dysfunction over the initial 2 years https://t.co/GGOpZ0RXIv
RT @JAMACardio: Over 2 years of follow-up, atrial shunting in patients with HFpEF and HFmrEF led to reverse remodeling of left-sided chambe…
RT @JAMACardio: Over 2 years of follow-up, atrial shunting in patients with HFpEF and HFmrEF led to reverse remodeling of left-sided chambe…
Over 2 years of follow-up, atrial shunting in patients with HFpEF and HFmrEF led to reverse remodeling of left-sided chambers and increases in volume of right-sided chambers but no change in RV systolic function compared with sham. https://t.co/qtdBf3VumJ https://t.co/BLpkoc2bAE